Novo Nordisk is intervening in the lawsuit filed by a drug compounders trade group against the FDA over the agency’s decision ...

The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.

A naturally occurring molecule identified by Stanford Medicine researchers appears similar to semaglutide—also known as ...

A large population-based cohort study reports that using GLP-1 RAs significantly reduces the risk for cardiovascular events ...

Patients with T2D who undergo kidney transplants are less likely to experience organ failure and mortality if they receive ...

The WEGOVY market has experienced significant growth, driven by rising obesity rates and increasing demand for effective weight-loss treatments. Novo Nordisk's blockbuster drug has seen strong ...

The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...

GLP-1 receptor agonists are transforming obesity treatment, but manufacturing challenges must be addressed to meet rising ...

Scientists at Novo Nordisk have demonstrated a photochemically enabled strategy for the functionalisation of peptides and ...

Back to Healio A retrospective study demonstrated that GLP-1 receptor agonist use before pregnancy corresponded with lower risks for hypertensive disorders of pregnancy, gestational diabetes ...